Annual Working Capital
$558.08 M
-$84.36 M-13.13%
December 31, 2023
Summary
- As of February 7, 2025, AVIR annual working capital is $558.08 million, with the most recent change of -$84.36 million (-13.13%) on December 31, 2023.
- During the last 3 years, AVIR annual working capital has risen by +$10.40 million (+1.90%).
- AVIR annual working capital is now -22.00% below its all-time high of $715.52 million, reached on December 31, 2021.
Performance
AVIR Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$461.72 M
-$18.03 M-3.76%
September 30, 2024
Summary
- As of February 7, 2025, AVIR quarterly working capital is $461.72 million, with the most recent change of -$18.03 million (-3.76%) on September 30, 2024.
- Over the past year, AVIR quarterly working capital has dropped by -$122.71 million (-21.00%).
- AVIR quarterly working capital is now -35.47% below its all-time high of $715.52 million, reached on December 31, 2021.
Performance
AVIR Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
AVIR Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.1% | -21.0% |
| 3 y3 years | +1.9% | -21.0% |
| 5 y5 years | +1594.3% | -21.0% |
AVIR Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -22.0% | at low | -35.5% | at low |
| 5 y | 5-year | -22.0% | +2765.6% | -35.5% | +2270.8% |
| alltime | all time | -22.0% | +2765.6% | -35.5% | +2270.8% |
Atea Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $461.72 M(-3.8%) |
| Jun 2024 | - | $479.75 M(-5.5%) |
| Mar 2024 | - | $507.45 M(-9.1%) |
| Dec 2023 | $558.08 M(-13.1%) | $558.08 M(-4.5%) |
| Sep 2023 | - | $584.42 M(-3.3%) |
| Jun 2023 | - | $604.67 M(-2.5%) |
| Mar 2023 | - | $620.03 M(-3.5%) |
| Dec 2022 | $642.44 M | $642.44 M(-3.6%) |
| Sep 2022 | - | $666.30 M(+0.3%) |
| Jun 2022 | - | $664.34 M(-3.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $684.62 M(-4.3%) |
| Dec 2021 | $715.52 M(+30.6%) | $715.52 M(+23.2%) |
| Sep 2021 | - | $580.89 M(-2.8%) |
| Jun 2021 | - | $597.46 M(+2.0%) |
| Mar 2021 | - | $585.87 M(+7.0%) |
| Dec 2020 | $547.68 M(+2712.2%) | $547.68 M(+461.2%) |
| Sep 2020 | - | $97.60 M(-12.4%) |
| Jun 2020 | - | $111.39 M(+472.0%) |
| Dec 2019 | $19.48 M(-40.9%) | $19.48 M |
| Dec 2018 | $32.94 M | - |
FAQ
- What is Atea Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals annual working capital year-on-year change?
- What is Atea Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals quarterly working capital year-on-year change?
What is Atea Pharmaceuticals annual working capital?
The current annual working capital of AVIR is $558.08 M
What is the all time high annual working capital for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high annual working capital is $715.52 M
What is Atea Pharmaceuticals annual working capital year-on-year change?
Over the past year, AVIR annual working capital has changed by -$84.36 M (-13.13%)
What is Atea Pharmaceuticals quarterly working capital?
The current quarterly working capital of AVIR is $461.72 M
What is the all time high quarterly working capital for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high quarterly working capital is $715.52 M
What is Atea Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, AVIR quarterly working capital has changed by -$122.71 M (-21.00%)